THIRD AMENDMENT TO LEASELease • August 6th, 2024 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledAugust 6th, 2024 Company IndustryTHIS THIRD AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 6th day of May, 2024, by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership (“Landlord”), and PROTAGONIST THERAPEUTICS, INC., a Delaware corporation (“Tenant”).